Human Apolipoprotein E Is Required for Infectivity and Production of Hepatitis C Virus in Cell Culture
Open accessThe DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Abstract
Recent advances in reverse genetics of hepatitis C virus (HCV) made it possible to determine the properties and biochemical compositions of HCV virions. Sedimentation analysis and characterization of HCV RNA-containing particles produced in the cultured cells revealed that HCV virions cover a large range of heterogeneous densities in sucrose gradient. The fractions of low densities are infectious, while the higher-density fractions containing the majority of HCV virion RNA are not. HCV core protein and apolipoprotein B and apolipoprotein E (apoE) were detected in the infectious HCV virions. The level of apoE correlates very well with HCV infectivity. Both apoE- and HCV E2-specific monoclonal antibodies precipitated HCV, demonstrating that HCV virions contain apoE and E2 proteins. apoE-specific monoclonal antibodies efficiently neutralized HCV infectivity in a dose-dependent manner, resulting in a reduction of infectious HCV by nearly 4 orders of magnitude. The knockdown of apoE expression by specific small interfering RNAs (siRNAs) remarkably reduced the levels of intracellular as well as secreted HCV virions. The apoE siRNA suppressed HCV production by more than 100-fold at 50 nM. These findings demonstrate that apoE is required for HCV virion infectivity and production, suggesting that HCV virions are assembled as apoE-enriched lipoprotein particles. Our findings also identified apoE as a novel target for discovery and development of antiviral drugs and monoclonal antibodies to suppress HCV virion formation and infection.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Continuous cultures of fused cells secreting antibody of predefined specificity
KÖHLER, G., & MILSTEIN, C. (1975) · Nature · doi:10.1038/256495a0 · Cited by 17,229
Isolation of a cDNA cLone Derived from a Blood-Borne Non-A, Non-B Viral Hepatitis Genome
Choo, Q.-L., Kuo, G., Weiner, A. J., Overby, L. R., Bradley, D. W., & Houghton, M. (1989) · Science · doi:10.1126/science.2523562 · Cited by 6,875
Replication of Subgenomic Hepatitis C Virus RNAs in a Hepatoma Cell Line
Lohmann, V., Körner, F., Koch, J.-O., Herian, U., Theilmann, L., & Bartenschlager, R. (1999) · Science · doi:10.1126/science.285.5424.110 · Cited by 2,814
Production of infectious hepatitis C virus in tissue culture from a cloned viral genome
Wakita, T., Pietschmann, T., Kato, T., Date, T., Miyamoto, M., Zhao, Z., Murthy, K., Habermann, A., Kräusslich, H.-G., Mizokami, M., et al. (2005) · Nature Medicine · doi:10.1038/nm1268 · Cited by 2,754
Complete Replication of Hepatitis C Virus in Cell Culture
Lindenbach, B. D., Evans, M. J., Syder, A. J., Wölk, B., Tellinghuisen, T. L., Liu, C. C., Maruyama, T., Hynes, R. O., Burton, D. R., McKeating, J. A., et al. (2005) · Science · doi:10.1126/science.1114016 · Cited by 2,238
Robust hepatitis C virus infection in vitro
Zhong, J., Gastaminza, P., Cheng, G., Kapadia, S., Kato, T., Burton, D. R., Wieland, S. F., Uprichard, S. L., Wakita, T., & Chisari, F. V. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0503596102 · Cited by 1,709
Efficient Initiation of HCV RNA Replication in Cell Culture
Blight, K. J., Kolykhalov, A. A., & Rice, C. M. (2000) · Science · doi:10.1126/science.290.5498.1972 · Cited by 1,412
Highly Permissive Cell Lines for Subgenomic and Genomic Hepatitis C Virus RNA Replication
Blight, K. J., McKeating, J. A., & Rice, C. M. (2002) · Journal of Virology · doi:10.1128/jvi.76.24.13001-13014.2002 · Cited by 1,193
The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus
Scarselli, E., Ansuini, H., Cerino, R., Roccasecca, R. M., Acali, S., Filocamo, G., Traboni, C., Nicosia, A., Cortese, R., & Vitelli, A. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf529 · Cited by 1,177
Genomic analysis of the host response to hepatitis C virus infection
Su, A. I., Pezacki, J. P., Wodicka, L., Brideau, A. D., Supekova, L., Thimme, R., Wieland, S., Bukh, J., Purcell, R. H., Schultz, P. G., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.202608199 · Cited by 1,161
Hepatitis C virus and other Flaviviridae viruses enter cells via low density lipoprotein receptor
Agnello, V., Ábel, G., Elfahal, M., Knight, G. B., & Zhang, Q.-X. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.22.12766 · Cited by 974
Egger, D., Wölk, B., Gosert, R., Bianchi, L., Blum, H. E., Moradpour, D., & Bienz, K. (2002) · Journal of Virology · doi:10.1128/jvi.76.12.5974-5984.2002 · Cited by 867
National Institutes of Health Consensus Development Conference Statement: Management of Hepatitis B
Sorrell, M. F., Belongia, E. A., Costa, J., Gareen, I. F., Grem, J. L., Inadomi, J. M., Kern, E. R., McHugh, J. A., Petersen, G. M., Rein, M. F., et al. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-150-2-200901200-00100 · Cited by 832
Characterization of Low- and Very-Low-Density Hepatitis C Virus RNA-Containing Particles
André, P., Komurian-Pradel, F., Deforges, S., Perret, M., Berland, J. L., Sodoyer, M., Pol, S., Bréchot, C., Paranhos-Baccalà, G., & Lotteau, V. (2002) · Journal of Virology · doi:10.1128/jvi.76.14.6919-6928.2002 · Cited by 690
Bartosch, B., Vitelli, A., Granier, C., Goujon, C., Dubuisson, J., Pascale, S., Scarselli, E., Cortese, R., Nicosia, A., & Cosset, F.-L. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m305289200 · Cited by 631
Efficient replication of the genotype 2a hepatitis C virus subgenomic replicon
Kato, T., Date, T., Miyamoto, M., Furusaka, A., Tokushige, K., Mizokami, M., & Wakita, T. (2003) · Gastroenterology · doi:10.1053/j.gastro.2003.09.023 · Cited by 590
Huang, H., Sun, F., Owen, D. M., Li, W., Chen, Y., Gale, M., & Ye, J. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0700760104 · Cited by 533
Reelin, lipoprotein receptors and synaptic plasticity
Herz, J., & Chen, Y. (2006) · Nature Reviews Neuroscience · doi:10.1038/nrn2009 · Cited by 524
Hepatitis C virus RNA replication is regulated by host geranylgeranylation and fatty acids
Kapadia, S. B., & Chisari, F. V. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409834102 · Cited by 511
Kolykhalov, A. A., Feinstone, S. M., & Rice, C. M. (1996) · Journal of Virology · doi:10.1128/jvi.70.6.3363-3371.1996 · Cited by 468
Fisher, E. A., & Ginsberg, H. N. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.r100068200 · Cited by 460
Wang, C., Sarnow, P., & Siddiqui, A. (1993) · Journal of Virology · doi:10.1128/jvi.67.6.3338-3344.1993 · Cited by 441
Equilibrium centrifugation studies of hepatitis C virus: evidence for circulating immune complexes
Hijikata, M., Shimizu, Y. K., Kato, H., Iwamoto, A., Shih, J. W., Alter, H. J., Purcell, R. H., & Yoshikura, H. (1993) · Journal of Virology · doi:10.1128/jvi.67.4.1953-1958.1993 · Cited by 373
Kissing-Loop Interaction in the 3′ End of the Hepatitis C Virus Genome Essential for RNA Replication
Friebe, P., Boudet, J., Simorre, J.-P., & Bartenschlager, R. (2005) · Journal of Virology · doi:10.1128/jvi.79.1.380-392.2005 · Cited by 371
Association of hepatitis C virus in human sera with ?-lipoprotein
Thomssen, R., Bonk, S., Propfe, C., Heermann, K.-H., K�chel, H. G., & Uy, A. (1992) · Medical Microbiology and Immunology · doi:10.1007/bf00198849 · Cited by 366
Nielsen, S. U., Bassendine, M. F., Burt, A. D., Martin, C., Pumeechockchai, W., & Toms, G. L. (2006) · Journal of Virology · doi:10.1128/jvi.80.5.2418-2428.2006 · Cited by 347
Evans, M. J., Rice, C. M., & Goff, S. P. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0405152101 · Cited by 339
Novel Insights into Hepatitis C Virus Replication and Persistence
Bartenschlager, R., Frese, M., & Pietschmann, T. (2004) · Advances in Virus Research · doi:10.1016/s0065-3527(04)63002-8 · Cited by 307
Wang, C., Gale, M., Keller, B. C., Huang, H., Brown, M. S., Goldstein, J. L., & Ye, J. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.04.004 · Cited by 299
Friebe, P., & Bartenschlager, R. (2002) · Journal of Virology · doi:10.1128/jvi.76.11.5326-5338.2002 · Cited by 291
Kapadia, S. B., Barth, H., Baumert, T., McKeating, J. A., & Chisari, F. V. (2007) · Journal of Virology · doi:10.1128/jvi.01134-06 · Cited by 271
Gastaminza, P., Kapadia, S. B., & Chisari, F. V. (2006) · Journal of Virology · doi:10.1128/jvi.01150-06 · Cited by 241
National Institutes of Health Consensus Development Conference: Management of Hepatitis C: 2002
Seeff, L. B., & Hoofnagle, J. H. (2002) · Hepatology · doi:10.1053/jhep.2002.36992 · Cited by 239
THOMSSEN, R., Bonk, S., & Thiele, A. (1993) · Medical Microbiology and Immunology · doi:10.1007/bf00191948 · Cited by 234
Hepatitis C therapeutics: current status and emerging strategies
Tan, S.-L., Pause, A., Shi, Y., & Sonenberg, N. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd937 · Cited by 197
Apolipoprotein E-ε4 protects against severe liver disease caused by hepatitis C virus
Wozniak, M. A., Itzhaki, R. F., Faragher, B. E., James, M. W., Ryder, S. D., & Irving, W. L. (2002) · Hepatology · doi:10.1053/jhep.2002.34745 · Cited by 181
Hepatitis C Virus Particles and Lipoprotein Metabolism
André, P., Perlemuter, G., Budkowska, A., Bréchot, C., & Lotteau, V. (2005) · Seminars in Liver Disease · doi:10.1055/s-2005-864785 · Cited by 180
Hepatitis C virus: Buoyant density if the factor VIII‐derived isolate in sucrose
Bradley, D., McCaustland, K., Krawczynski, K., Spelbring, J., Humphey, C., & Cook, E. H. (1991) · Journal of Medical Virology · doi:10.1002/jmv.1890340315 · Cited by 165
El‐Hage, N., & Luo, G. G. (2003) · Journal of General Virology · doi:10.1099/vir.0.19305-0 · Cited by 135
Self-citationInternal Ribosome Entry Site-Mediated Translation in Hepatitis C Virus Replication
Rijnbrand, R. C. A., & Lemon, S. M. (2000) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-59605-6_5 · Cited by 124
Roles of apolipoproteins B and E in the cellular binding of very low density lipoproteins.
Krul, E. S., Tikkanen, M. J., Cole, T. G., Davie, J. M., & Schonfeld, G. (1985) · Journal of Clinical Investigation · doi:10.1172/jci111708 · Cited by 110
Konan, K. V., Giddings, T. H., Ikeda, M., Li, K., Lemon, S. M., & Kirkegaard, K. (2003) · Journal of Virology · doi:10.1128/jvi.77.14.7843-7855.2003 · Cited by 108
Apolipoprotein ε3 allele is associated with persistent hepatitis C virus infection
Price, D. A., Bassendine, M. F., Norris, S. M., Golding, C., Toms, G. L., Schmid, M. L., Morris, C. M., Burt, A. D., & Donaldson, P. T. (2006) · Gut · doi:10.1136/gut.2005.079905 · Cited by 94
Cited by
The HCV Life Cycle: In vitro Tissue Culture Systems and Therapeutic Targets
Gerold, G., & Pietschmann, T. (2014) · Digestive Diseases · doi:10.1159/000360830 · Cited by 4,854
Dengue Virus-Induced Autophagy Regulates Lipid Metabolism
Heaton, N. S., & Randall, G. (2010) · Cell Host & Microbe · doi:10.1016/j.chom.2010.10.006 · Cited by 705
Understanding the hepatitis C virus life cycle paves the way for highly effective therapies
Scheel, T. K. H., & Rice, C. M. (2013) · Nature Medicine · doi:10.1038/nm.3248 · Cited by 554
Assembly of infectious hepatitis C virus particles
Bartenschlager, R., Penin, F., Lohmann, V., & André, P. (2011) · Trends in Microbiology · doi:10.1016/j.tim.2010.11.005 · Cited by 453
The molecular and structural basis of advanced antiviral therapy for hepatitis C virus infection
Bartenschlager, R., Lohmann, V., & Penin, F. (2013) · Nature Reviews Microbiology · doi:10.1038/nrmicro3046 · Cited by 402
Metadata
- Authors
- Chang, K.-S., Jiang, J., Cai, Z., & Luo, G.
- Venue
- Journal of Virology
- Publisher
- American Society for Microbiology
- Published
- 2007-12-15
- Volume
- 81
- Issue
- 24
- Pages
- 13783-13793
- ISSN
- 0022-538X (ISSN-L)
- 1098-5514
- OpenAlex
- W2105291849
- Cited by
- 424
- References
- 43
- FWCI
- 16.00
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.